[1] Buonfrate D, Ferrari T C A, Adegnika A A, et al. Human schistosomiasis[J]. Lancet (London, England), 2025, 405(10479): 658-670.
[2] Yao X, Chen Y, Chen K, et al. Prevention and control of schistosomiasis in the Philippines from a health education perspective[J]. Front Public Health, 2025, 13: 1558564.
[3] Díaz de León Derby M, Delahunt C B, Spencer E, et al. Multi-contrast machine learning improves schistosomiasis diagnostic performance[J]. PLoS NTDs, 2025, 19(8): e0012879.
[4] Alfred M O, Ochola L, Okeyo K, et al. Application of microphysiological systems to unravel the mechanisms of schistosomiasis egg extravasation[J]. Front Cell Infect Mi, 2025, 15: 1521265.
[5] Rasoamanamihaja C F, Rakotoarivelo R A, Edosoa G, et al. Schistosomiasis elimination in Madagascar: challenges and opportunities for implementing the new WHO guidelines[J]. BMJ global health, 2023, 8(8): e012598.
[6] 林楚焱, 汪坤坤, 张 坤, 等. 抗血吸虫药物吡喹酮的合成研究[J]. 遵义医科大学学报,2025,48(4):380-385.
[7] Waechtler A, Cezanne B, Maillard D, et al. Praziquantel-50 years of research[J]. ChemMedChem, 2023, 18(12): e202300154.
[8] El Kouni M H. Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets[J]. Comp Biochem Phys B, 2017, 213: 55-80.
[9] Spangenberg T. Alternatives to praziquantel for the prevention and control of schistosomiasis[J]. ACS infectious diseases, 2021, 7(5): 939-942.
[10] Henthorn C R, McCusker P, Le Clec'h W, et al. Transcriptional phenotype of the anti-parasitic benzodiazepine meclonazepam on the blood fluke Schistosoma mansoni[J]. PLoS NTDs, 2025, 19(4): e0012969.
[11] Gui X, Lv R, Zhong H, et al. Praziquantel pretreatment reduces schistosoma japonicum infection in mice by targeting immature worm stages[J]. Trop Med Infect Dis, 2025, 10(9): 262.
[12] Gui X, Shao B, Zhong H, et al. Effect of praziquantel on preventing delayed infection of schistosoma japonicum in buffaloes and goats[J]. Microorganisms, 2024, 13(1): 17.
[13] Kokaliaris C, Garba A, Matuska M, et al. Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study[J].Lancet Infect Dis, 2022, 22(1): 136-149.
[14] Kovac J, Meister I, Neodo A, et al. Pharmacokinetics of praziquantel in schistosoma mansoni- and schistosoma haematobium-infected school- and preschool-aged children[J]. AAC, 2018, 62(8): e02253-17.
[15] Mnkugwe R H, Minzi O S, Kinung'hi S M, et al. Efficacy and safety of praziquantel for treatment of schistosoma mansoni infection among school children in Tanzania[J]. Pathogens (Basel, Switzerland), 2019, 9(1): 28.
[16] 赵晋英, 刘 鹏, 李艳伟, 等. 血吸虫病联合用药的研究进展[J]. 中国寄生虫学与寄生虫病杂志,2020,38(3):370-377.
[17] Shaw J R, Brammer K W. The treatment of experimental schistosomiasis with a combination of oxamniquine and praziquantel[J]. T Roy Soc Trop Med Hyg, 1983, 77(1): 39-40.
[18] Alhusseiny S M, El-Beshbishi S N, Abu Hashim M M, et al. Effectiveness of vinpocetine and isosorbide-5-mononitrate on experimental schistosomiasis mansoni: Biochemical and immunohistochemical study[J]. Acta Tropica, 2018, 186: 16-23.
[19] Salama W M, El-Naggar S A, Harras S F, et al. An adjuvant effect of Metformin as an anti-fibrotic agent when administered with the anti-schistosomal Praziquantel in Schistosoma mansoni infected mice[J]. Trop Biomed, 2021, 38(2): 205-213.
[20] Sabra A N A, Salem M B, William S, et al. Optimizing the therapeutic benefits of synriam combined with praziquantel in mice harbouring juvenile and mature Schistosoma mansoni[J]. Sci Rep, 2025, 15(1): 28867.
[21] Mahmoud T Y, Rizk S M, Maghraby A S, et al. Propolis enhances the effectiveness of praziquantel in experimental schistosomiasis: biochemical and histopathological study[J]. Parasitol Res, 2014, 113(12): 4513-4523.
[22] Mnkugwe R H, Minzi O, Kinung'hi S, et al. Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: A randomized, non-inferiority clinical trial[J]. PLoS NTDs, 2020, 14(9): e0008619.
[23] 李洪军, 陶永辉, 戴建荣, 等. 感染日本血吸虫小鼠用双氢青蒿素连续给药及与吡喹酮伍用的疗效观察[J]. 中国血吸虫病防治杂志,2010,22(6):534-538.
[24] 侯循亚. 蒿甲醚与吡喹酮联合治疗急性日本血吸虫病的临床研究[D]. 长沙:中南大学, 2006.
[25] Atwa M T M, Abd-Elrazek A M, Salem N I S. Dandelion (taraxacum officinale) improves the therapeutic efficiency of praziquantel in experimental schistosomiasis[J]. Acta Parasitologica, 2022, 67(2): 773-783.
[26] 胡 伟. 日月贝多糖联用吡喹酮对血吸虫肝纤维化的干预及机制研究[D]. 芜湖:皖南医学院, 2017.
[27] 高思佳, 王素蓉, 许琼明, 等. 白头翁总皂苷与青蒿琥酯或者吡喹酮联用对日本血吸虫的杀灭作用[J]. 热带医学杂志,2013,13(10):1210-1213.
[28] 黄大可. 吡喹酮及噁二唑类衍生物抗日本血吸虫作用的初步研究[D]. 合肥:安徽医科大学, 2012.
[29] 孙 缓. 吡喹酮新衍生物抗日本血吸虫生物学效应研究[D]. 苏州:苏州大学, 2013.
[30] 陈祥钊. NO供体吡喹酮—硝酸酯和噁二唑-2-氧化物合成与抗日本血吸虫作用研究[D]. 赣州:赣南师范学院, 2015.
[31] 杨子吟. 吡喹酮及其衍生物DW-3-15抗日本血吸虫协同作用及分子机制研究[D]. 苏州:苏州大学, 2021.
[32] 刘子浩. 吡喹酮衍生物DW-3-15作用于潜在靶点组蛋白乙酰转移酶(HAT)抗血吸虫的分子机制[D]. 苏州:苏州大学, 2022.
[33] Dong L, Duan W, Chen J, et al. An artemisinin derivative of praziquantel as an orally active antischistosomal agent[J]. PLoS One, 2014, 9(11): e112163.
[34] Wang X, Yu D, Li C, et al. In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum[J]. Parasites & Vectors, 2019, 12(1): 199.
[35] Duan W wen, Qiu S jie, Zhao Y, et al. Praziquantel derivatives exhibit activity against both juvenile and adult Schistosoma japonicum[J].Bioorg Med Chem, 2012, 22(4): 1587-1590.
[36] Wang Z xia, Chen J lei, Qiao C. Praziquantel derivatives with antischistosomal activity: aromatic ring modification[J]. Chem Biol Drug Des, 2013, 82(2): 216-225.
[37] Angeli A, Ferraroni M, Carta F, et al. Development of Praziquantel sulphonamide derivatives as antischistosomal drugs[J]. J Enzyme Inhib Med Chem, 2022, 37(1): 1479-1494.
[38] 郑新生. 吡喹酮透皮给药系统的研究及对日本血吸虫病的试验治疗[D]. 武汉:华中农业大学, 2008.
[39] 王 磊. 吡喹酮蒸发透皮给药系统的研究及其应用[D]. 武汉:华中农业大学, 2010.
[40] Mengarda A C, Iles B, Rodrigues V C, et al. Correction to “Praziquantel Nanoparticle Formulation for the Treatment of Schistosomiasis”[J].ACS Appl Nano Mater,2025, 8(22): 11730.
[41] 丛朝彤. 温敏型吡喹酮纳米乳凝胶缓释系统的优化设计及体内外评价[D]. 兰州:兰州大学, 2018.
[42] Ghazy R M, Tahoun M M, Abdo S M, et al. Evaluation of praziquantel effectivenss after decades of prolonged use in an Endemic Area in Egypt[J]. Acta Parasitologica, 2021, 66(1): 81-90.
[43] 梁幼生. 我国血吸虫对吡喹酮抗药性研究之概要[J]. 中国热带医学,2019,19(7):603-607.
[44] Kasinathan R S, Morgan W M, Greenberg R M. Genetic knockdown and pharmacological inhibition of parasite multidrug resistance transporters disrupts egg production in Schistosoma mansoni[J]. PLoS NTDs, 2011, 5(12): e1425.
[45] Kasinathan R S, Morgan W M, Greenberg R M. Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel[J].Mol Biochem Parasit, 2010, 173(1): 25-31.
[46] Messerli S M, Kasinathan R S, Morgan W, et al. Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility[J].Mol Biochem Parasit, 2009, 167(1): 54-59.
[47] Rohr C M, Sprague D J, Park S K, et al. Natural variation in the binding pocket of a parasitic flatworm TRPM channel resolves the basis for praziquantel sensitivity[J]. PNAS, 2023, 120(1): e2217732120.
[48] Chulkov E G, Palygin O, Yahya N A, et al. Electrophysiological characterization of a schistosome transient receptor potential channel activated by praziquantel[J]. Int J Parasitol, 2023, 53(8): 415-425.
[49] Abou-El-Naga I F. Schistosoma mansoni sarco/endoplasmic reticulum Ca²⁺ ATPases (SERCA): role in reduced sensitivity to praziquantel[J]. J Bioenerg Biomembr, 2020, 52(5): 397-408.
[50] Abou-El-Naga I F. Calcium/calmodulin-dependent protein kinase Ⅱ in Schistosoma: relation to praziquantel action and resistance[J]. Mol Biochem Parasit, 2025, 263: 111686.
[51] Abou-El-Naga I F. Heat shock protein 70 (Hsp70) in Schistosoma mansoni and its role in decreased adult worm sensitivity to praziquantel[J]. Parasitology, 2020, 147(6): 634-642.
[52] Petukhova V Z, Aboagye S Y, Ardini M, et al. Non-covalent inhibitors of thioredoxin glutathione reductase with schistosomicidal activity in vivo[J]. Nature Communications, 2023, 14(1): 3737.